• The Pistoia Alliance Announces Number of Reactions in its Chemical Safety Library Service has Increased Four-Fold

    Aug 22, 2018, 05:44 AM by Michael Croft
    BOSTON, MA - Aug 23, 2018 - The Pistoia Alliance, a global, not for profit alliance that works to lower barriers to innovation in life sciences R&D, is today announcing a number of milestones in its Chemical Safety Library (CSL) Service project, launched in March 2017
    Full story
  • Bionano Genomics Announces Pricing Of Initial Public Offering

    Aug 21, 2018, 13:05 PM by Michael Croft

    Bio-IT World News Brief | Bionano Genomics today announced the pricing of its initial public offering of 3,360,000 units at a public offering price of $6.125 per unit for aggregate gross proceeds of $20,580,000, before deducting the underwriting discounts and commissions and offering expenses.

    Full story
  • Scientists at the MDI Biological Laboratory Identify New Genetic Regulators of Regeneration

    Aug 21, 2018, 11:27 AM by Michael Croft
    BAR HARBOR, ME, UNITED STATES - Aug 21, 2018 - Scientists at the MDI Biological Laboratory and the University of Maine have discovered that genetic material in the cell that was previously thought to be “junk” because of its apparent lack of function likely plays a part in regulating genetic circuits responsible for regeneration in highly regenerative animals
    Full story
  • MD Anderson Spins Out Neurosciences Company From Discovery Division

    Aug 20, 2018, 10:25 AM by Michael Croft

    Bio-IT World News Brief | The University of Texas MD Anderson Cancer Center and Accelerator Life Science Partners, a leading life science investment and management firm, have announced the launch of Magnolia Neurosciences Corporation, a company developing a new class of neuroprotective medicines, with $31 million in Series A funding.

    Full story
  • CRF Health Launches Self-Service Model for TrialConsent® Platform

    Aug 20, 2018, 09:05 AM by Michael Croft
    PLYMOUTH MEETING, PA - Aug 20, 2018 - CRF Health, the leading global provider of patient-centered eSource technology and service solutions for the life sciences industry, launches a self-service capability and a customer enablement program to empower CROs and Sponsors to manage all aspects of electronic informed consent using a licensed, cloud-based version of the industry’s first electronic informed consent platform with fully embedded design tool
    Full story
  • BOC Sciences Extends Its Services to Medicinal Chemistry Field

    Aug 17, 2018, 23:43 PM by Michael Croft
    SHIRLEY, NY, UNITED STATES - Aug 18, 2018 - Recently the New York based chemical supplier—BOC Sciences launches a series of solutions to cover medicinal chemistry field
    Full story
  • Dealing With Fast Growing Data With Hyperscale Data Distribution

    Aug 17, 2018, 08:00 AM by Michael Croft

    Bio-IT World Contributed Commentary | The biopharmaceutical industry is facing fast growing data movement challenges. The optimization of the data movement setup must be done in a holistic manner, not by each stack separately.

    Full story
  • Life Biosciences Funds MDI Biological Laboratory Aging Course

    Aug 16, 2018, 13:14 PM by Michael Croft
    BAR HARBOR, ME, UNITED STATES - Aug 16, 2018 - The MDI Biological Laboratory has announced that Life Biosciences, a biotech company co-founded by David Sinclair, Ph
    Full story
  • Clouds And Collaboration: How St. Jude Built The Team That Built The St. Jude Cloud

    Aug 16, 2018, 11:15 AM by Michael Croft

    Bio-IT World | In April of this year St. Jude Children’s Research Hospital launched the St. Jude Cloud, an online data-sharing and collaboration platform that provides researchers access to the world's largest public repository of pediatric cancer genomics data. What started with St. Jude’s isolated bioinformatics frustrations has expanded to a vision for global collaboration in pediatric oncology.

    Full story
  • Creative Diagnostics Launches Humanized Monoclonal Antibodies for Assay Development

    Aug 16, 2018, 03:07 AM by Michael Croft
    SHIRLEY, NY, UNITED STATES - Aug 16, 2018 - As a global leader in the manufacture of raw materials, antibodies, and reagents for bio-technology industry, Creative Diagnostics announced today that it has launched a newly developed set of humanized monoclonal antibodies (IgM, IgG or IgA) that can be used as calibrators, positive, negative or quality controls in assay development and manufacturing of diagnostic kits for global life science researchers
    Full story
  • CIO Perspective: Creating Community On Campus At St. Jude

    Aug 15, 2018, 11:45 AM by Michael Croft

    Bio-IT World | The process of creating the St. Jude Cloud was a difficult one for St. Jude Children’s Research Hospital. But St. Jude’s CIO and chair of Computational Biology believe the relationships cultivated during the process will create a user community as much within St. Jude as without.

    Full story
  • Certara’s D360 Version 10.5 Extends Platform’s Ability to Optimize Discovery Research Across Therapeutic Modalities

    Aug 15, 2018, 09:33 AM by Michael Croft
    PRINCETON, NJ - Aug 15, 2018 - Certara®, the global leader in model-informed drug development, regulatory science, market access and real-world evidence services, today announced the launch of D360 v10
    Full story
  • Clues To Your Health Are Hidden At 6.6 Million Spots In Your DNA

    Aug 14, 2018, 13:16 PM by Michael Croft
    The New York Times | With a sophisticated new algorithm, scientists have found a way to forecast an individual's risks for five deadly diseases.
    Full story
  • ActiveRADAR Expands Leadership Team to Support Industry Demand, Company Momentum

    Aug 14, 2018, 11:00 AM by Michael Croft
    SACRAMENTO, CA, UNITED STATES - Aug 14, 2018 - ActiveRADAR (formerly known as RxTE Health), a company specializing in pharmacy cost reduction programs for employers, today announced the addition of three healthcare executives to its leadership team
    Full story
  • OmniTier’s CompStor Brings De Novo Analytics To Genomics

    Aug 14, 2018, 08:05 AM by Michael Croft

    Bio-IT World News Brief | OmniTier announced that in a joint study with researchers at the Mayo Clinic’s Center for Individualized Medicine, the company successfully demonstrated human DNA variant calling using de novo global assembly techniques with breakthrough performance and cost.

    Full story
  • MDI Biological Laboratory Announces Morris Scientific Discovery Fund

    Aug 13, 2018, 13:24 PM by Michael Croft
    BAR HARBOR, ME, UNITED STATES - Aug 13, 2018 - The MDI Biological Laboratory has announced the formation of the Morris Scientific Discovery Fund, which will provide a total of up to $250,000 per year for eligible research programs
    Full story
  • Tjoapack launches postponement packaging service

    Aug 13, 2018, 11:55 AM by Michael Croft
    ETTEN-LEUR, NETHERLANDS - Aug 13, 2018 - Global contract packaging organisation (CPO), Tjoapack has launched a new postponement packaging service to help customers address supply chain challenges including variable demand and repackaging work
    Full story
  • The Future Of Humans As Model Organisms

    Aug 13, 2018, 10:14 AM by Michael Croft
    Science | A better grasp of the dynamic relationship between genes and the environment may truly sharpen our ability to determine disease risk and response to therapy, argues a recent perspective essay in Science.
    Full story
  • BC Platforms and Negen Announce Partnership for Early Risk Assessment of Common Diseases

    Aug 9, 2018, 16:07 PM by Michael Croft
    BASEL, SWITZERLAND - Aug 8, 2018 - BC Platforms, a world leader in genomic data management and analytics, today announces that it has signed a co-operation agreement with Negen to use its platform to provide detailed insights into raw genomic data for clinical reporting capabilities
    Full story
  • KEY BIOLOGICS AND ASTARTE BIOLOGICS MERGE

    Aug 9, 2018, 08:47 AM by Michael Croft
    MEMPHIS, TN, UNITED STATES - Aug 9, 2018 - KEY BIOLOGICS AND ASTARTE BIOLOGICS MERGEIncludes growth equity investment from Ampersand Capital PartnersKey Biologics, has completed its merger withAstarte Biologics to create the leading provider of research- and clinical-grade human immune cells, blood products, and related services to the biopharmaceutical industry
    Full story